Cell-Surface Protein Prediction for Cancer Target Prioritization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods lack an efficient and systematic approach to prioritize among multiple potential cell surface targets for cancer therapies, necessitating a method to predict cell-surface protein expression in cancer cells to enhance therapy specificity and minimize toxicities.
Innovation Solution
A prediction model is developed using gene expression profiles and normalization techniques to rank and quantify cell-surface protein expression, enabling identification of optimal targets for therapy based on gene expression data and clinical trial information.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple cell surface targets are evaluated for cancer therapy, then therapy effectiveness can be improved, but the complexity of target selection and prioritization increases
Solution Approach 1:
The patent replaces manual, expert-driven target selection processes with an automated computational system that uses machine learning models and algorithms to evaluate and prioritize cell surface targets based on gene expression data, thereby reducing the complexity of target selection while maintaining or improving therapy effectiveness
Solution Approach 2:
The patent creates a computational model that copies and simulates the complex biological evaluation process, using in silico predictions to replicate the function of extensive experimental testing and expert assessment, allowing for efficient target prioritization without requiring exhaustive physical experimentation
2Reliability
If cell surface targeted therapies are used to increase cancer cell specificity, then therapy effectiveness improves, but the need for accurate target identification becomes more critical
Solution Approach 1:
The patent introduces gene expression data as an intermediary measurement that correlates with cell surface protein expression, allowing for indirect but accurate assessment of target availability without requiring direct protein measurement, thus maintaining measurement precision while enabling high-throughput target evaluation
Solution Approach 2:
The patent transforms the measurement approach by changing from direct protein expression measurement to gene expression measurement, utilizing the relationship between mRNA and protein levels to accurately predict cell surface target expression through computational models
3Measurement precision
If comprehensive gene expression profiling is performed to identify optimal targets, then target selection accuracy improves, but the time and computational resources required increase
Solution Approach 1:
The patent performs preliminary computational analysis and model training on large gene expression datasets before actual target selection, creating pre-computed models and databases that can rapidly predict target expression for new cases, thereby reducing the time required for individual target identification while maintaining accuracy
Solution Approach 2:
The patent divides the comprehensive target evaluation process into separate computational modules and steps, including data preprocessing, model training, feature selection, and prediction stages, allowing for efficient processing and parallel computation that reduces overall analysis time while maintaining selection accuracy
Data Source
AI summary
Models and methods for predicting cell-surface protein expression, such as expression of cell-surface targets on cancer cells.